2023 November ACSoMP recommendations

Summary and recommendations from the third joint meeting of the WHO Advisory Committee on Safety of Medicinal Products (ACSOMP) and WHO Global Advisory Committee on Vaccine Safety (GACVS).

Overview

The third joint meeting of the WHO Advisory Committee on Safety of Medicinal Products (ACSoMP) and WHO Global Advisory Committee on Vaccine Safety (GACVS) occurred between the 13 to 15 November 2023 at WHO Headquarters in Geneva, Switzerland. The two advisory Committees meet twice a year, in May (independently) and in November (jointly). A summary of the discussions and recommendations from the medicines-specific sessions and from sessions of common interest for the pharmacovigilance of both medicines and vaccines is provided below. The medicines-specific sessions were chaired by Dr Gerald Dal Pan from the United States Food and Drug Administration (US FDA) and sessions common to both vaccines and medicines were co-chaired by Dr Dure Samin Akram from the Health, Education and Literacy Program in Pakistan, Dr Rita Helfand, Centre of Disease Control (CDC), United States and Dr Gerald Dal Pan.

 

WHO Team
Pharmacovigilance (PVG)
Editors
The World Health Organization
Number of pages
5